Cordance Medical is developing the NeuroAccess™ system, a non-invasive ultrasound device that reversibly opens the blood-brain barrier using low-frequency focused ultrasound and microbubbles. This technology enables targeted delivery of therapeutics and diagnostic biomarkers to the brain, addressing the challenge of drug delivery for conditions such as brain cancers, Alzheimer's, and Parkinson's disease.
Funding
$12.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The blood-brain barrier (BBB) prevents effective drug delivery and biomarker measurement for brain diseases, hindering the treatment of conditions like brain cancers, Alzheimer's, Parkinson's, and Epilepsy. Current methods struggle to overcome this barrier, limiting therapeutic options and diagnostic capabilities.
Solution
Cordance Medical is developing the NeuroAccess™ system, a non-invasive ultrasound device designed to reversibly open the blood-brain barrier. The system uses low-frequency focused ultrasound and microbubbles to temporarily disrupt the BBB, enabling targeted delivery of therapeutics and diagnostic biomarkers to specific areas of the brain. This approach aims to improve treatment efficacy for brain cancers, Alzheimer's, Parkinson's, and Epilepsy by allowing drugs to reach the affected tissues and enabling blood tests for disease diagnosis and tracking. The NeuroAccess™ system facilitates precision medicine by providing a patient-friendly and repeatable method for accessing the brain.
Target Audience
The primary target audience includes patients with brain cancers, Alzheimer's, Parkinson's, and Epilepsy, as well as clinicians and pharmaceutical companies focused on developing and delivering therapies for these conditions.
Features
- Non-invasive BBB opening using low-frequency focused ultrasound and microbubbles
- Targeted drug delivery to specific brain regions
- Enables blood tests for diagnostic biomarker measurement
- Reversible BBB opening for repeatable treatments
- Patient-friendly design suitable for outpatient settings
- Approved patent and multiple pending patents related to the device and its applications